Chronic Total Occlusion

"Chronic total occlusions bring their own challenges. They come in a big spectrum of lesions. ...you have to have good technology and solutions to overcome those specific challenges.6"

Be the Next CTO Expert

Push the boundaries of innovation. Leverage the hybrid approach to treat chronic total occlusions safely – with maximum efficiency and success. Boston Scientific can help you build your CTO program with specialized training, unique tools, and ongoing case support. Partner with us to bridge coronary CTOs.

Common Occurrence

CTOs are very common, occurring in as many as 30% of patients with significant coronary artery disease.1,2

CABG vs PCI

Patients with CTOs are most often treated with medical therapy or coronary artery bypass graft (CABG) rather than PCI.

CTO PCI

Recent meta-analyses and large registries have shown that successful CTO PCI is associated with symptom relief, a reduction in long-term mortality, and a lower need for coronary artery bypass graft (CABG) surgery.3,4,5

Join Our Complex PCI Community

Stay up-to-date via email on the latest advances in complex PCI.

Sign-up Today

CTO PCI Education & Training

BSC is Advancing the Treatment of Re-Entry System Coronary CTOs around the Globe

Explore our training program

Related Technologies

CrossBoss™ Coronary CTO Crossing Catheter

Stingray™ Coronary CTO Re-Entry System

SYNERGY™ Everolimus-Eluting Platinum Chromium Coronary Stent System

TRAPPER™ Exchange Device

Top